Australia markets closed

Intra-Cellular Therapies Inc (23I.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
61.000.00 (0.00%)
As of 08:03AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
512,287
462,175
249,132
81,708
22,531
Cost of revenue
36,894
33,745
20,443
8,035
1,895
Gross profit
475,393
428,430
228,689
73,673
20,636
Operating expenses
Research development
184,951
180,142
134,715
88,845
65,782
Selling general and administrative
424,026
409,864
358,782
272,611
186,364
Total operating expenses
607,334
587,811
492,315
359,361
251,864
Operating income or loss
-131,941
-159,381
-263,626
-285,688
-231,228
Income before tax
-109,883
-139,038
-256,250
-284,120
-226,992
Income tax expense
985
636
6
6
14
Income from continuing operations
-110,868
-139,674
-256,256
-284,126
-227,006
Net income
-110,868
-139,674
-256,256
-284,126
-227,006
Net income available to common shareholders
-110,868
-139,674
-256,256
-284,126
-227,006
Basic EPS
-1.62
-1.46
-2.72
-3.50
-3.23
Diluted EPS
-1.62
-1.46
-2.72
-3.50
-3.23
Basic average shares
95,499
95,882
94,047
81,253
70,365
Diluted average shares
95,499
95,882
94,047
81,253
70,365